EUVIMEDEUVIMED entdecken
Crossref

Progressive cone dystrophy in PDE6C-associated achromatopsia with a likely pathogenic variant and a VUS

Mia O'Connell, Jian Kong, Megan Soucy, Scott E Brodie, Stephen H Tsang

Documenta Ophthalmologica · 29.07.2026

DOI: 10.1007/s10633-026-10136-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Documenta Ophthalmologica, online erschienen am 29.07.2026. Verfasst von Mia O'Connell und 4 weiteren Autor:innen. Beteiligte Einrichtung: Jonas Children's Vision Care and Bernard & Shirlee Brown Glaucoma Laboratory, Inst of Human Nutrition, Columbia Stem Cell Initiative, New York, NY, U…. Die Arbeit nennt 16 Literaturangaben. Gefördert von: Jonas Children's Vision Care, supported by the National Institute of Health, Foundation Fighting Blindness, Richard Jaffe, NYEE Foundation, the Rosenbaum Family Foundation, the Gebroe Family Foundation, the Research to Prevent Blindness (RPB) Physician-Scientist Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To report the clinical phenotype, multimodal imaging findings, and electrophysiologic characteristics of a 62-year-old patient with achromatopsia harboring two heterozygous PDE6C (NM_006204.3) variants: a variant of uncertain significance, c.2248G > C (p.Asp750His), and a likely pathogenic variant, c.2304_2305delAA (p.Asp770Ter).

Methods

The patient underwent comprehensive ophthalmic evaluation, including best-corrected visual acuity (BCVA), slit-lamp examination, dilated fundus examination, spectral-domain optical coherence tomography (SD-OCT), fundus autofluorescence (FAF), and full-field electroretinography (ffERG) according to ISCEV standards. Genetic testing was performed using whole-exome sequencing (WES).

Results

BCVA was 20/300 in both eyes at the most recent visit. Ten months earlier, BCVA was 20/150 in the right eye and 20/100 in the left eye. Fundus examination demonstrated bilateral central macular atrophic lesions with corresponding autofluorescence abnormalities. SD-OCT revealed irregular attenuation and focal loss of the ellipsoid zone with relative preservation of the retinal pigment epithelium. ffERG showed severe cone dysfunction, characterized by markedly reduced light-adapted single-flash responses and near-extinguished 30 Hz flicker responses, with relatively preserved rod-mediated scotopic responses. Genetic testing identified two heterozygous PDE6C variants: a likely pathogenic frameshift variant (c.2304_2305delAA; p.Asp770Ter), predicted to result in premature truncation of the protein, and a missense variant (c.2248G > C; p.Asp750His) located in the catalytic phosphodiesterase domain, not previously reported, and currently classified as a variant of uncertain significance.

Conclusions

This case expands the phenotypic spectrum of PDE6C -associated retinal disease by describing a severe cone dysfunction phenotype with clinical features consistent with achromatopsia. In the context of an autosomal recessive condition, the presence of a likely pathogenic variant alongside a variant of uncertain significance, combined with a consistent clinical and electrophysiologic phenotype, supports a possible biallelic disease mechanism. These findings contribute to emerging genotype–phenotype correlations and may aid in interpreting rare PDE6C variants.

Schlagwörter

Stichwörter der Autor:innen

AchromatopsiaElectroretinographyGeneticsPhosphodiesterase 6C

Autor:innen und Institutionen

  • Jonas Children's Vision Care and Bernard & Shirlee Brown Glaucoma Laboratory, Inst of Human Nutrition, Columbia Stem Cell Initiative, New York, NY, USA.
  • Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York-Presbyterian Hospital, New York, NY, USA.
  • Department of Ophthalmology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
  • Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
  • Jonas Children's Vision Care and Bernard & Shirlee Brown Glaucoma Laboratory, Inst of Human Nutrition, Columbia Stem Cell Initiative, New York, NY, USA. sht2@cumc.columbia.edu.
  • Department of Ophthalmology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA. sht2@cumc.columbia.edu.

Förderung

  • Jonas Children's Vision Care, supported by the National Institute of Health
  • Foundation Fighting Blindness
  • Richard Jaffe, NYEE Foundation, the Rosenbaum Family Foundation, the Gebroe Family Foundation, the Research to Prevent Blindness (RPB) Physician-Scientist Award

Zitieren

APA

O'Connell, M., Kong, J., Soucy, M., Brodie, S. E., & Tsang, S. H. (2026). Progressive cone dystrophy in PDE6C-associated achromatopsia with a likely pathogenic variant and a VUS. Documenta Ophthalmologica. https://doi.org/10.1007/s10633-026-10136-4

Vancouver

O'Connell M, Kong J, Soucy M, Brodie SE, Tsang SH. Progressive cone dystrophy in PDE6C-associated achromatopsia with a likely pathogenic variant and a VUS. Documenta Ophthalmologica. 2026. doi:10.1007/s10633-026-10136-4

BibTeX
@article{OConnell2026,
  author = {O'Connell, Mia and Kong, Jian and Soucy, Megan and Brodie, Scott E and Tsang, Stephen H},
  title = {Progressive cone dystrophy in PDE6C-associated achromatopsia with a likely pathogenic variant and a VUS},
  journal = {Documenta Ophthalmologica},
  year = {2026},
  doi = {10.1007/s10633-026-10136-4}
}
Kostenlos starten →